Viewing Study NCT00771394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-01-24 @ 7:15 PM
Study NCT ID: NCT00771394
Status: COMPLETED
Last Update Posted: 2013-02-15
First Post: 2008-10-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Benign Prostatic Hyperplasia View
None Benign Prostatic Hypertrophy View
None Overactive Bladder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vesicare View
None Solifenacin succinate View
None Tamsulosin View
None Overactive Bladder View
None BPH View